Immuno-Oncology 360°

Immuno-Oncology 360° in New York on Wednesday, February 6, 2019
Immuno-Oncology 360° in New York on Wednesday, February 6, 2019
Wednesday, February 6, 2019 -- Friday, February 8, 2019, 0800 - 1600
The Immuno-Oncology 360° Summit reports on the rapid advancements of clinical, scientific, and business developments of IO in one setting for a wider range of cancers at an accelerated rate.

The 5th annual Immuno-Oncology (IO) 360° is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate.
The 3 day summit features 10 plenary sessions with over 80 speakers and includes over 10 hours of networking. There will be over 450 attendees representing pharma, biotech, academia, research organizations, business development and the investment community focused on IO. Designed by Dr Axel Hoos, GSK, Dr James Gulley, NCI, and Dr Andrew Baum, Citi, the IO360° program addresses aspects from all facets of IO including:
Discovery/Preclinical Science
Translational Science
Clinical Data Development
Clinical Operations
Cell Therapy
Imaging Aspects
Emerging Technologies
Business Aspects
Emerging Technologies
Financial & Commercial Implications
Trends in the Field
The IO360° Summit reports on the most current data and rapid advancements to help IO stakeholders:
Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
Foster collaboration amongst those working in all aspects of cancer immunotherapy together
Partner to expand technology platforms to develop therapeutics at an accelerated rate
Receive the latest pre-clinical, translational, and clinical data from academic and industry
Identify and gain a greater understanding of what assets are available for potential combinations
Create and prioritize strategies targeted toward specific tumor types
Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
Get key investor and analyst insights on the IO landscape, challenges, investment decision-making & next steps
Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more
Obtain coverage on a wide range of emerging technologies

On Wednesday February 6, 2019 at 8:00 am (ends Friday February 8, 2019 at 4:00 pm)

Category: Conferences - Science, Health & Medicine - Oncology

Price:

Industry / Pharma and Biotech starting rate: USD 1995.0
Standard Industry starting rate: USD 1995.0
Academia, Non-Profit & Government starting rate: USD 997.5

Venue: Crowne Plaza Times Square Manhattan, 1605 Broadway, New York, 10019

Links:

Website: https://go.evvnt.com/288750-0?pid=2874
Tickets: https://go.evvnt.com/288750-2?pid=2874
Brochure: https://go.evvnt.com/288750-3?pid=2874
Booking: https://go.evvnt.com/288750-4?pid=2874
Starting Price Per Person
$ 997.50 USD
Other Information
Where
Crowne Plaza Times Square Manhattan
1605 Broadway
New York 10019
United States
( Convention - Exhibition Center )

                 
Event Organizer Contact
Margaret Van Cleve
service@tcfllc.org
646-350-2580
More Events
Event ID: 137997

Get Events in Your Inbox

We have over 100,000 Events in 80+ Categories. Tell us what type of events you like, and we will send them to your inbox


  •    
  •